<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04963400</url>
  </required_header>
  <id_info>
    <org_study_id>RL_2021_1</org_study_id>
    <nct_id>NCT04963400</nct_id>
  </id_info>
  <brief_title>Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity</brief_title>
  <official_title>Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity (Inpatient Troponin T)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to examine, whether hospitalization is associated with higher high-sensitivity cardiac&#xD;
      troponin T (hs-cTnT) serum concentrations in patients without a cardiac disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-sensitivity cardiac troponin T (hs-cTnT) values will be obtained in hospitalized&#xD;
      patients a) without a diagnosed or suspected cardiac disease, and b) with an acute medical&#xD;
      condition that is not commonly associated with an increase of hs-cTnT concentrations. As a&#xD;
      reference, a second sampling of blood for an analysis of the hs-cTnT serum concentration will&#xD;
      be obtained in the same patients after discharge (60 days after hospitalization).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2021</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of the hs-cTnT concentration at hospitalization and after discharge</measure>
    <time_frame>60 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of low severity</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of medium severity</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of high severity</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of 1-year-mortality by hs-cTnT concentration</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of 1-year-hospitalization rate due to a cardiovascular disease by hs-cTnT concentration</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">312</enrollment>
  <condition>Non-cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Patients with low disease severity</arm_group_label>
    <description>Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of low severity (e.g. patients with retinal detachment)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with medium disease severity</arm_group_label>
    <description>Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of medium severity (e.g. patients with an uncomplicated acute pancreatitis oder an acute exacerbation of a chronic inflammatory bowel disease)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with high disease severity</arm_group_label>
    <description>Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of high severity (e.g. patients with a proximal femoral fracture)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Analysis of hs-cTnT serum concentration at hospitalization</intervention_name>
    <description>Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization</description>
    <arm_group_label>Patients with high disease severity</arm_group_label>
    <arm_group_label>Patients with low disease severity</arm_group_label>
    <arm_group_label>Patients with medium disease severity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Analysis of hs-cTnT serum concentration after discharge</intervention_name>
    <description>Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)</description>
    <arm_group_label>Patients with high disease severity</arm_group_label>
    <arm_group_label>Patients with low disease severity</arm_group_label>
    <arm_group_label>Patients with medium disease severity</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        312 patients with an acute, non-cardiac medical condition of low, medium or high severity&#xD;
        (104 patients per group)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  hospitalization due to a non-cardiac disease&#xD;
&#xD;
          -  age â‰¥ 50 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  diagnosed or suspected cardiac disease&#xD;
&#xD;
          -  acute medical conditions commonly associated with a myocardial injury (e.g.&#xD;
             circulatory shock, sepsis, pulmonary embolism, cerebral infarction, acute renal&#xD;
             failure)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rolf Wachter, MD</last_name>
    <phone>+493419711376</phone>
    <email>rolf.wachter@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Romy Langhammer, MD</last_name>
    <phone>+493419711376</phone>
    <email>romy.langhammer@medizin.uni-leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Leipzig Medical Center</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Wachter, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>July 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Rolf Wachter</investigator_full_name>
    <investigator_title>Professor MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Available upon reasonable scientific request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

